RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
2 hedge funds and large institutions have $2.98M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 210 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 210
Holders
2
Holding in Top 10
–
Calls
$16.5M
Puts
$50.7M
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$295M | |
| 2 | -$288M | |
| 3 | -$259M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$180M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$152M |
